Mariateresa Cipriano

机构：GlaxoSmithKline (India), San Francisco Department of Public Health, ID Genomics (United States) · ORCID：0000-0001-6644-7137

发表论文 39 篇 · 总被引 1811 次 · h-index 17

代表论文

• Global trends in antibiotic consumption during 2016–2023 and future projections through 2030 (2024 · Proceedings of the National Academy of Sciences · 被引 374)
• A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis (2014 · Angewandte Chemie International Edition · 被引 132)
• A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis (2014 · Angewandte Chemie · 被引 84)
• Cannabidiol Improves Vasorelaxation in Zucker Diabetic Fatty Rats through Cyclooxygenase Activation (2014 · Journal of Pharmacology and Experimental Therapeutics · 被引 56)
• Palmitoylethanolamide inhibits rMCP-5 expression by regulating MITF activation in rat chronic granulomatous inflammation (2014 · European Journal of Pharmacology · 被引 34)
• Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis <i>In Vitro</i> (2015 · CNS & Neurological Disorders - Drug Targets · 被引 30)